5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with Neurofibromatosis 2 in 1 studies
5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist
Neurofibromatosis 2: An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (NEURILEMMOMA) of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the NF2 gene (GENES, NEUROFIBROMATOSIS 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamleiter, M | 1 |
| Hanemann, CO | 1 |
| Kluwe, L | 1 |
| Rosenbaum, C | 1 |
| Wosch, S | 1 |
| Mautner, VF | 1 |
| Müller, HW | 1 |
| Grafe, P | 1 |
1 other study available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and Neurofibromatosis 2
| Article | Year |
|---|---|
Voltage-dependent membrane currents of cultured human neurofibromatosis type 2 Schwann cells.
Topics: Chloride Channels; Humans; Membrane Potentials; Neurilemmoma; Neurofibromatosis 2; Nitrobenzoates; P | 1998 |